Prevalence of N-methyl-D-aspartate receptor autoantibodies in the peripheral blood: healthy control samples revisited.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  JAMA psychiatry

• Publication date

  2014-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1001/jamapsychiatry.2014.469PMID 24871043
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.

  2014cited by this paper
• Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood–brain barrier integrity

  2014cited by this paper
• Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study

  2014cited by this paper
• The clinical utility of a positive antinuclear antibody test result.

  2013cited by this paper
• Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis.

  2013cited by this paper
• Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features

  2012cited by this paper
• Autoimmune markers in diabetes.

  2011cited by this paper
• Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

  2011cited by this paper

• Neuronal autoantibodies in neurodegenerative dementia: From evidence to clinical framework.

  2026cites this paper
• Antibodies in neurological diseases: Established, emerging, explorative

  2024cites this paper
• Cerebrospinal fluid characteristics of patients presenting for evaluation of pediatric acute-neuropsychiatric syndrome

  2024cites this paper
• Serum anti-NMDA receptor antibodies are linked to memory impairment 12 months after stroke

  2024cites this paper
• N-Methyl-d-Aspartate Receptor Antibody and Sensory Gating Deficits in Non-smoking, Minimal Antipsychotic Medication Exposure, and First-Episode Patients With Schizophrenia.

  2024cites this paper
• Chemotherapy-induced cognitive impairment and its long-term development in patients with breast cancer: results from the observational CICARO study

  2024cites this paper
• Cross‐sectional analysis reveals autoantibody signatures associated with COVID‐19 severity

  2023cites this paper
• Autoimmune encephalitis: recent clinical and biological advances

  2023cites this paper
• Depressive symptoms and anti-N-methyl-D-aspartate-receptor GluN1 antibody seropositivity in the PROSpective cohort with incident stroke

  2023cites this paper
• Pediatric anti-NMDA-receptor autoimmune encephalitis in siblings: Developmental, Electrophysiologic, and Genetic Implications.

  2023cites this paper
• Differenzialdiagnosen der akuten und akut-transienten psychotischen Störung // Differential diagnostics of acute and acute transient psychotic disorders

  2022cites this paper
• The Immune System and Depression: From Epidemiological to Clinical Evidence.

  2022cites this paper
• Journal Pre-proof Anti-neuronal autoantibodies in the cerebrospinal fluid and serum from 106 patients with recent onset depression compared to 106 individually matched healthy controls

  2022cites this paper
• Antineuronal Autoantibodies in the Cerebrospinal Fluid and Serum From 106 Patients With Recent-Onset Depression Compared With 106 Individually Matched Healthy Control Subjects

  2022influential citation
• “Obvious” indications for Neural antibody testing in Epilepsy or Seizures: The ONES checklist

  2022cites this paper
• Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels

  2021cites this paper
• Antibodies against N-Methyl D-Aspartate Receptor in Psychotic Disorders: A Systematic Review

  2021cites this paper
• The diverse and complex modes of action of anti-NMDA receptor autoantibodies.

  2021cites this paper
• Chronic presence of blood circulating anti-NMDAR1 autoantibodies impairs cognitive function in mice

  2021cites this paper
• Cognitive Impact by Blood Circulating Anti-NMDAR1 Autoantibodies

  2021cites this paper
• Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis

  2020cites this paper
• Association of thyroid peroxidase antibodies with anti-neuronal surface antibodies in health, depression and schizophrenia- complementary linkage with somatic symptoms of major depression.

  2020cites this paper
• ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS PRESENTING AS POSTPARTUM PSYCHOSIS: A CASE REPORT

  2020cites this paper
• Psychiatric Symptoms of Patients With Anti-NMDA Receptor Encephalitis

  2020cites this paper
• In vivo Mechanisms of Antibody-Mediated Neurological Disorders: Animal Models and Potential Implications

  2020cites this paper
• Multiple inducers and novel roles of autoantibodies against the obligatory NMDAR subunit NR1: a translational study from chronic life stress to brain injury

  2020cites this paper
• Serum anti-NMDA-receptor antibodies and cognitive function after ischemic stroke (PROSCIS-B)

  2020cites this paper
• Autoimmune encephalitis with psychosis: Warning signs, step-by-step diagnostics and treatment

  2020cites this paper
• Novel approaches to measure physiological and behavioral responses to stress

  2020cites this paper
• Influence of methodological and patient factors on serum NMDAR IgG antibody detection in psychotic disorders: a meta-analysis of cross-sectional and case-control studies.

  2020cites this paper
• Anti-N-Methyl-D-Aspartate Receptor Encephalitis in Psychiatry.

  2019cites this paper
• Serum Anti-NMDA (N-Methyl-D-Aspartate)-Receptor Antibodies and Long-Term Clinical Outcome After Stroke (PROSCIS-B).

  2019cites this paper
• Clinically Relevant Anti-Neuronal Cell Surface Antibodies in Schizophrenia Spectrum Disorders

  2019cites this paper
• Anti-NMDA-receptor antibody in initial diagnosis of mood disorder.

  2019cites this paper
• [Autoimmune encephalitis with psychotic symptoms : Diagnostics, warning signs and practical approach].

  2018cites this paper
• Optimization of an Anti-NMDA Receptor Autoantibody Diagnostic Bioassay

  2018cites this paper
• Patient characteristics and outcome associations in AMPA receptor encephalitis

  2018cites this paper
• Anti-NMAR-Enzephalitis — Mimikry der schizophrenen Erstmanifestation

  2018cites this paper
• A clinical approach to new-onset psychosis associated with immune dysregulation: the concept of autoimmune psychosis

  2018cites this paper
• Autoimmunenzephalitis mit psychotischer Symptomatik

  2018cites this paper
• Autoimmune phenotypes in schizophrenia reveal novel treatment targets

  2018cites this paper
• Clinical significance of IgM and IgA class anti-NMDAR antibodies in herpes simplex encephalitis.

  2018cites this paper
• Uncoupling the widespread occurrence of anti-NMDAR1 autoantibodies from neuropsychiatric disease in a novel autoimmune model

  2018cites this paper
• Autoantibodies against N-methyl-d-aspartate receptor 1 in health and disease

  2018cites this paper
• Pathogenicity of Antibodies against NMDA Receptor: Molecular Insights into Autoimmune Psychosis.

  2018cites this paper
• Inhibition of NMDA receptor function with an anti-GluN1-S2 antibody impairs human platelet function and thrombosis

  2017cites this paper
• Increased serum anti-N-methyl-D-aspartate receptor antibody immunofluorescence in psychiatric patients with past catatonia

  2017cites this paper
• Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients

  2017cites this paper
• Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms

  2017cites this paper
• Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression?

  2017cites this paper
• Synaptic and Neuronal Autoantibody-Associated Psychiatric Syndromes: Controversies and Hypotheses

  2017cites this paper
• High prevalence of neuronal surface autoantibodies associated with cognitive deficits in cancer patients

  2017cites this paper
• Autoantibodies against the N-Methyl-d-Aspartate Receptor Subunit NR1: Untangling Apparent Inconsistencies for Clinical Practice

  2017cites this paper
• All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class

  2017cites this paper
• Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia

  2017cites this paper
• Detecting synaptic autoantibodies in psychoses: need for more sensitive methods

  2017cites this paper
• Molecular requirements involving the human platelet protease-activated receptor-4 mechanism of activation by peptide analogues of its tethered-ligand

  2017cites this paper
• Anti‐NMDA receptor encephalitis: clinical characteristics, predictors of outcome and the knowledge gap in southwest China

  2016cites this paper
• The role of NMDAR antibody in the etiopathogenesis of schizophrenia

  2016influential citation
• The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.

  2016cites this paper
• Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care

  2016influential citation
• Anti-NMDA receptor encephalitis, autoimmunity, and psychosis.

  2016cites this paper
• Anti-NMDA Receptor Encephalitis, Autoimmunity, and Psychosis.

  2016cites this paper
• Diagnostic algorithms in autoimmune encephalitis

  2016cites this paper
• Anti-NMDA (N-metil-D-aszparaginsav) receptor enkefalitisz: irodalmi összefoglaló, esetismertetés és kutatási terv.

  2016cites this paper
• Prevalence of elevated serum anti-N-methyl-D-aspartate receptor antibody titers in patients presenting exclusively with psychiatric symptoms: a comparative follow-up study

  2016cites this paper
• Protein Interaction Networks Link Schizophrenia Risk Loci to Synaptic Function

  2016cites this paper
• The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment.

  2016cites this paper
• Absence of N-Methyl-D-Aspartate Receptor IgG Autoantibodies in Schizophrenia: The Importance of Cross-Validation Studies.

  2015cites this paper
• Role of Immune and Autoimmune Dysfunction in Schizophrenia

  2015cites this paper
• Response to Steiner and Bogerts on N-methyl-d-aspartate receptor autoantibodies in schizophrenia and affective disorders.

  2015cites this paper
• Schizophrenia and psychoneuroimmunology: an integrative view

  2015cites this paper
• Autoimmune Encephalitis in Postpartum Psychosis.

  2015cites this paper
• Antineuronal Antibodies Against Neurotransmitter Receptors and Synaptic Proteins in Schizophrenia: Current Knowledge and Clinical Implications

  2015cites this paper
• Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications

  2015cites this paper
• Short report Open Access

  2015cites this paper
• Immunological findings in psychotic syndromes: a tertiary care hospital's CSF sample of 180 patients

  2015cites this paper
• Preexisting Serum Autoantibodies Against the NMDAR Subunit NR1 Modulate Evolution of Lesion Size in Acute Ischemic Stroke

  2015cites this paper
• N-Methyl-d-aspartate receptor autoantibodies in schizophrenia and affective disorders.

  2015cites this paper
• High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types

  2014cites this paper
• Absence of dopamine receptor serum autoantibodies in schizophrenia patients with an acute disease episode.

  2014cites this paper
• Seroprevalence of autoantibodies against brain antigens in health and disease

  2014cites this paper
• Autoimmune encephalitis - History & current knowledge

  2012cites this paper